Jones will likely remain the lead back, but it’s wise to protect the 30-year-old while also creating a formidable 1-2 punch when they’re both healthy. Plus, Jones did endure some fumbling ...

The FDA has accepted an investigational new drug (IND) application to launch the phase 1/2 Oncorella ... 4 orellanine demonstrated the ability to target primary and metastatic clear-cell RCC in vitro ...

It seems as though the jury's still out on whether or not the Kansas City Chiefs made the right moves during free agency. While they have been addressing their team needs, fans are still ...

Here are our initial grades: Acquired: OG Kenyon Green ... to work out better for the Eagles in the long run? Also yes. Grade: C+ Acquired: S C.J. Gardner-Johnson, 2026 sixth-round pick On ...

The poll found 47% approve of how he is handling his job while 45% disapprove—a 2-point increase from last week’s survey. “Despite not yet delivering on the economy in voters’ minds ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Preoperative ...

"To our knowledge, this is the first study to report on the utility of tumor-informed ctDNA in a cohort of patients with nonmetastatic RCC," the researchers ... of 5.2% at 4 years (91.2% vs ...